5-bromobenzo[d]isoxazol-3-one

5-bromobenzo[d]isoxazol-3-one Suppliers list
Company Name: Shanghai Synthfine Chemical Co.,Ltd  
Tel: 15921303235
Email: sales@synthfine.com
Company Name: Shanghai Keepontech Co.,Ltd  
Tel: 021-54849683 13601642561
Email: sales@keepontech.com
Company Name: SynAsst Chemical.  
Tel: 021-60343070
Email:
Company Name: Shanghai Xingui Biotechnology Co., Ltd.  
Tel: 15121041756
Email: xingui2022@126.com
Company Name: ShangHai AmK Pharmaceutical Technology Co., Ltd.  
Tel: 微信 18019252918 18019252918
Email: sale@amkchem.com
5-bromobenzo[d]isoxazol-3-one Basic information
Product Name:5-bromobenzo[d]isoxazol-3-one
Synonyms:5-bromobenzo[d]isoxazol-3-one;5-broMo-1,2-benzoxazol-3-ol;5-BroMobenzo[d]isoxazol-3(2H)-one;5-Bromobenzo[d]isoxazol-3(2H);5-bromo-1,2-benzoxazol-3-one;1,2-Benzisoxazol-3(2H)-one, 5-bromo-;5-Bromobenzisoxazol-3(2H)-one;5-bromo-2,3-dihydro-1,2-benzoxazol-3-one
CAS:65685-50-9
MF:C7H4BrNO2
MW:214.02
EINECS:
Product Categories:
Mol File:65685-50-9.mol
5-bromobenzo[d]isoxazol-3-one Structure
5-bromobenzo[d]isoxazol-3-one Chemical Properties
Melting point 202-203 °C
density 1.809±0.06 g/cm3(Predicted)
storage temp. 2-8°C
pka13.30±0.20(Predicted)
AppearanceOff-white to light brown Solid
Safety Information
MSDS Information
5-bromobenzo[d]isoxazol-3-one Usage And Synthesis
Synthesis
5-Bromo-N,2-dihydroxybenzamide

5798-94-7

5-bromobenzo[d]isoxazol-3-one

65685-50-9

The general procedure for the synthesis of 5-bromobenzo[d]isoxazol-3(2H)-one from the compound (CAS:5798-94-7) was as follows: thionyl chloride (10 ml) was added slowly and dropwise to a solution of δ-bromosalicylcarbamic acid F2 (21.6 g) in tetrahydrofuran (60 ml) under stirring conditions at 10-200 °C. Stirring of the reaction mixture was continued for 2 hours by maintaining the same temperature. Subsequently, the reaction mixture was evaporated under reduced pressure to remove the solvent, the residue was dissolved in dioxane (60 ml) and the solution was cooled to 0-50 °C. To this cooled reaction mixture triethylamine (38 ml) was added and stirred at 37 °C. After that, the reaction mixture was allowed to stand at room temperature for 1 hour. The solvent was again removed by evaporation under reduced pressure and ice water (300 mL) was added to the residue. The pH of the mixture was adjusted to 2 using concentrated hydrochloric acid, at which point crystals were precipitated, and the precipitated crystals were collected by filtration and washed with water. Finally, the target compound F3 was purified by recrystallization from ethyl acetate to give the target compound F3 (17.5 g, 88% yield) as colorless needle-like crystals.

References[1] Patent: WO2011/20615, 2011, A1. Location in patent: Page/Page column 75; 76
[2] Journal of Medicinal Chemistry, 2008, vol. 51, # 12, p. 3357 - 3359
[3] Patent: US2015/175560, 2015, A1. Location in patent: Paragraph 0468; 0470
5-bromobenzo[d]isoxazol-3-one Preparation Products And Raw materials
Raw materials5-Bromo-N,2-dihydroxybenzamide-->1,4-Dioxane-->Thionyl chloride-->Tetrahydrofuran-->Triethylamine
Tag:5-bromobenzo[d]isoxazol-3-one(65685-50-9) Related Product Information
5-bromobenzo[d]isoxazol-3-one 1,2-Benzisoxazol-3(2H)-one, 6-bromo- 1,2-Benzisoxazol-3(2H)-one,6-fluoro-(9CI) 6-Chlorobenzo[d]isoxazol-3-ol 1,2-Benzisoxazol-3(2H)-one, 5,6-dibromo- 1,2-Benzisoxazol-3(2H)-one, 5-bromo-6-chloro-